Going Concern (unchanged) — Substantial doubt about ability to continue as going concern remains disclosed in both filings.
Delisting (improved) — Received Nasdaq delisting notice January 2026 for bid price below $1; regained compliance February 2026.

NASDAQ: HURA TuHURA Biosciences, Inc./NV 10-K

TuHURA closes Kineta acquisition, starts Phase 3 trial, but cash dwindles to $3.6M

Filed March 31, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 31, 2025 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade HURA commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 3, 2026 11:30 PM